已收盤 07-25 16:00:00 美东时间
+0.880
+0.69%
15 analysts have expressed a variety of opinions on Oshkosh (NYSE:OSK) over the...
07-23 06:00
DA Davidson analyst Michael Shlisky maintains Oshkosh (NYSE:OSK) with a Buy and raises the price target from $111 to $148.
07-22 22:48
从全员素养提升计划到赋能内部影响者,CIO正通过升级变革管理策略,推动生成式AI的落地应用并释放业务价值。 (图片由AI生成) ✦ 变革管理成AI规模化的...
07-18 12:01
行业专家分析,中东氢能项目开发商正凭借近年试运经验和在建产能优势,竞逐亚洲及欧洲低碳氢/氨招标市场。 标普全球大宗商品数据显示,该地区共有67个低碳或可...
07-15 10:37
今日重点评级关注:摩根大通:维持Cogent Biosciences"超配"评级,目标价从25美元升至29美元;摩根士丹利:维持Legend Biotech"超配"评级,目标价从80美元升至81美元
07-11 09:04
UBS analyst Steven Fisher maintains Oshkosh (NYSE:OSK) with a Buy and raises the price target from $119 to $149.
07-11 05:49
Oshkosh's (NYSE:OSK) short percent of float has fallen 13.55% since its last re...
07-11 01:00
Oshkosh Defense LLC, an Oshkosh Corporation (NYSE:OSK) business, has received orders from the U.S. Army valued at $167 million for 225 trucks and 54 trailers under the Family of Heavy Tactical Vehicles contract. These
07-03 01:36
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1147088025548091392.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Leerink Partners:维持再鼎医药(ZLAB)"跑赢大市"评级,目标价从73美元升至75美元</p> <p>• 美银证券:维持BioCryst Pharma(BCRX)"买入"评级,目标价从13美元升至15美元
07-02 09:54
Mitsui OSKLines ( ($JP:9104) ) has provided an announcement. Mitsui O.S.K. Line...
07-01 07:52